Skip to main content
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging 11/2003

01.11.2003 | Original Article

Usefulness of 18F-FDG PET in intrahepatic cholangiocarcinoma

verfasst von: Young-Jin Kim, Mijin Yun, Woo Jung Lee, Kyung Sik Kim, Jong Doo Lee

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 11/2003

Einloggen, um Zugang zu erhalten

Abstract

Surgical resection is the only curative treatment strategy for intrahepatic cholangiocarcinoma (CC). Therefore, accurate staging is essential for appropriate management of patients with CC. We assessed the usefulness of 2-[18F]fluoro-2-deoxy-d-glucose (FDG) positron emission tomography (PET) in the staging of CC. We undertook a retrospective review of FDG PET images in 21 patients (10 female, 11 male; mean age 57 years) diagnosed with CC. Ten patients had hilar CC and 11, peripheral CC. Patients underwent abdominal magnetic resonance imaging (MRI) (n=20) and computed tomography (CT) (n=12) for the evaluation of primary tumours, and chest radiography and whole-body bone scintigraphy for work-up of distant metastases. For semi-quantitative analysis, the maximum voxel standardised uptake value (SUVmax) was obtained from the primary tumour. All peripheral CCs showed intensely increased FDG uptake, and some demonstrated ring-shaped uptake corresponding to peripheral rim enhancement on CT and/or MRI. In nine of the ten patients, hilar CCs demonstrated increased FDG uptake of a focal nodular or linear branching appearance. The remaining case was false negative on FDG PET. One patient with a false negative result on MRI demonstrated increased uptake on FDG PET. Among the ten hilar CCs, FDG uptake was intense in only two patients and was slightly higher than that of the hepatic parenchyma in the remaining patients. For the detection of lymph node metastasis, FDG PET and CT/MRI were concordant in 16 patients, and discordant in five (FDG PET was positive in three, and CT and MRI in two). FDG PET identified unsuspected distant metastases in four of the 21 patients; all of these patients had peripheral CC. FDG PET is useful in detecting the primary lesion in both hilar and peripheral CC and is of value in discovering unsuspected distant metastases in patients with peripheral CC. FDG PET could be useful in cases of suspected hilar CC with non-confirmatory biopsy and radiological findings.
Literatur
1.
Zurück zum Zitat Ros PR, Buck JL, Goodman ZD, Ros AMV, Olmsted WW. Intrahepatic cholangiocarcinoma: radiologic-pathologic correlation. Radiology 1988; 176:689–693. Ros PR, Buck JL, Goodman ZD, Ros AMV, Olmsted WW. Intrahepatic cholangiocarcinoma: radiologic-pathologic correlation. Radiology 1988; 176:689–693.
2.
Zurück zum Zitat Edmonson HA, Craig JR. Peripheral cholangiocarcinoma. In: Schiff L, Schiff ER, eds. Disease of the liver. Philadelphia: J.B. Lippincott; 1984:1130–1136. Edmonson HA, Craig JR. Peripheral cholangiocarcinoma. In: Schiff L, Schiff ER, eds. Disease of the liver. Philadelphia: J.B. Lippincott; 1984:1130–1136.
3.
Zurück zum Zitat Kawarada Y, Mizumoto R. Diagnosis and treatment of cholangiocellular carcinoma of the liver. Hepatogastroenterology 1990; 37:176–181.PubMed Kawarada Y, Mizumoto R. Diagnosis and treatment of cholangiocellular carcinoma of the liver. Hepatogastroenterology 1990; 37:176–181.PubMed
4.
Zurück zum Zitat Schlinkert RT, Nagorney DM, van Heerden JA, Adson MA. Intrahepatic cholangiocarcinoma; clinical aspects, pathology and treatment. HPB Surg 1992; 5:95–101.PubMed Schlinkert RT, Nagorney DM, van Heerden JA, Adson MA. Intrahepatic cholangiocarcinoma; clinical aspects, pathology and treatment. HPB Surg 1992; 5:95–101.PubMed
5.
Zurück zum Zitat Haug CE, Jenkins RL, Rohrer RJ, Auchincloss H, Delmonico FL, Freeman RB, Lewis WD, Cosimi AB. Liver transplantation for primary hepatic cancer. Transplantation 1992; 53:376.PubMed Haug CE, Jenkins RL, Rohrer RJ, Auchincloss H, Delmonico FL, Freeman RB, Lewis WD, Cosimi AB. Liver transplantation for primary hepatic cancer. Transplantation 1992; 53:376.PubMed
6.
Zurück zum Zitat Hoh CK, Hawkins RA, Glaspy JA, Dahlbom M, Tse NY, Hoffman EJ, Schiepers C, Choi Y, Rege S, Nitzsche E. Cancer detection with whole-body PET using 2-[18F] fluoro-2-deoxy-d-glucose. J Comput Assist Tomogr 1993; 17:582–589.PubMed Hoh CK, Hawkins RA, Glaspy JA, Dahlbom M, Tse NY, Hoffman EJ, Schiepers C, Choi Y, Rege S, Nitzsche E. Cancer detection with whole-body PET using 2-[18F] fluoro-2-deoxy-d-glucose. J Comput Assist Tomogr 1993; 17:582–589.PubMed
7.
Zurück zum Zitat Keiding S, Hansen SB, Rasmussen HH, Gee A, Kruse A, Roelsgaard K, Tage-Jensen U, Dahlerup JF. Detection of cholangiocarcinoma in primary sclerosing cholangitis by positron emission tomography. Hepatology 1998; 28:700–706.PubMed Keiding S, Hansen SB, Rasmussen HH, Gee A, Kruse A, Roelsgaard K, Tage-Jensen U, Dahlerup JF. Detection of cholangiocarcinoma in primary sclerosing cholangitis by positron emission tomography. Hepatology 1998; 28:700–706.PubMed
8.
Zurück zum Zitat Widjaja A, Mix H, Wagner S, Graz KF, van den Hoff J, Petrich T, Meier PN, Manns MP. Positron emission tomography and cholangiocarcinoma in primary sclerosing cholangitis. Z Gastroenterol 1999; 37:731–733.PubMed Widjaja A, Mix H, Wagner S, Graz KF, van den Hoff J, Petrich T, Meier PN, Manns MP. Positron emission tomography and cholangiocarcinoma in primary sclerosing cholangitis. Z Gastroenterol 1999; 37:731–733.PubMed
9.
Zurück zum Zitat Okazumi S, Isono K, Enomoto K, Kikuchi T, Ozaki M, Yamamoto H, Hayashi H, Asano T, Ryu M. Evaluation of liver tumors using fluorine-18-fluorodeoxyglucose PET: characterization of tumor and assessment of effect of treatment. J Nucl Med 1992; 33:333–339.PubMed Okazumi S, Isono K, Enomoto K, Kikuchi T, Ozaki M, Yamamoto H, Hayashi H, Asano T, Ryu M. Evaluation of liver tumors using fluorine-18-fluorodeoxyglucose PET: characterization of tumor and assessment of effect of treatment. J Nucl Med 1992; 33:333–339.PubMed
10.
Zurück zum Zitat Fritscher-Ravens A, Bohuslavizki KH, Broering DC, Jenicke L, Schafer H, Buchert R, Rogiers X, Clausen M. FDG PET in the diagnosis of hilar cholangiocarcinoma. Nucl Med Commun 2001; 22:1277–1285.CrossRefPubMed Fritscher-Ravens A, Bohuslavizki KH, Broering DC, Jenicke L, Schafer H, Buchert R, Rogiers X, Clausen M. FDG PET in the diagnosis of hilar cholangiocarcinoma. Nucl Med Commun 2001; 22:1277–1285.CrossRefPubMed
11.
Zurück zum Zitat Kluge R, Schmidt F, Caca K, Barthel H, Hesse S, Georgi P, Seese A, Huster D, Berr F. Positron emission tomography with [18F]fluoro-2-deoxy-d-glucose for diagnosis and staging of bile duct cancer. Hepatology 2001; 33:1029–1035.PubMed Kluge R, Schmidt F, Caca K, Barthel H, Hesse S, Georgi P, Seese A, Huster D, Berr F. Positron emission tomography with [18F]fluoro-2-deoxy-d-glucose for diagnosis and staging of bile duct cancer. Hepatology 2001; 33:1029–1035.PubMed
12.
Zurück zum Zitat Kato T, Tsukamoto E, Kuge Y, Katoh C, Nambu T, Nobuta A, Kondo S, Asaka M, Tamaki N. Clinical role of18F-FDG PET for initial staging of patients with extrahepatic bile duct cancer. Eur J Nucl Med Mol Imaging 2002; 29:1047–1054.CrossRefPubMed Kato T, Tsukamoto E, Kuge Y, Katoh C, Nambu T, Nobuta A, Kondo S, Asaka M, Tamaki N. Clinical role of18F-FDG PET for initial staging of patients with extrahepatic bile duct cancer. Eur J Nucl Med Mol Imaging 2002; 29:1047–1054.CrossRefPubMed
13.
Zurück zum Zitat Okuda K, Kubo Y, Okazaki N, Arishima T, Hashimoto M. Clinical aspects of intrahepatic bile dut carcinoma including hilar carcinoma: a study of 57 autopsy proven cases. Cancer 1977; 39:232–246.PubMed Okuda K, Kubo Y, Okazaki N, Arishima T, Hashimoto M. Clinical aspects of intrahepatic bile dut carcinoma including hilar carcinoma: a study of 57 autopsy proven cases. Cancer 1977; 39:232–246.PubMed
14.
Zurück zum Zitat Soyer P, Bluemke DA, Reichle R, Calhoun PS, Bliss DF, Scherrer A, Fishman EK. Imaging of intrahepatic cholangiocarcinoma. 1. Peripheral cholangiocarcinoma. AJR 1995; 165:1427–1431. Soyer P, Bluemke DA, Reichle R, Calhoun PS, Bliss DF, Scherrer A, Fishman EK. Imaging of intrahepatic cholangiocarcinoma. 1. Peripheral cholangiocarcinoma. AJR 1995; 165:1427–1431.
15.
Zurück zum Zitat Nakeeb A, Pitt HA, Sohn TA, Coleman J, Abrams RA, Piantadosi S, Hruban RH, Lillemoe KD, Yeo CJ, Cameron JL. Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg 1996; 224:463–475.PubMed Nakeeb A, Pitt HA, Sohn TA, Coleman J, Abrams RA, Piantadosi S, Hruban RH, Lillemoe KD, Yeo CJ, Cameron JL. Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg 1996; 224:463–475.PubMed
16.
Zurück zum Zitat Worawattanakul S, Semelka R, Noone TC, Calvo BF, Kelekis NL, Woosley JT. Cholangiocarcinoma: spectrum of appearance on MR images using current techniques. Magn Reson Imaging 1998; 16:993–1003.CrossRefPubMed Worawattanakul S, Semelka R, Noone TC, Calvo BF, Kelekis NL, Woosley JT. Cholangiocarcinoma: spectrum of appearance on MR images using current techniques. Magn Reson Imaging 1998; 16:993–1003.CrossRefPubMed
17.
Zurück zum Zitat Shreve PD, Anzai Y, Wahl RL. Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants. Radiographics 1999; 19:61–77.PubMed Shreve PD, Anzai Y, Wahl RL. Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants. Radiographics 1999; 19:61–77.PubMed
18.
Zurück zum Zitat Hamrick-Turner J, Abbitt PL, Ros PR. Intrahepatic cholangiocarcinoma: MR appearance. AJR 1992; 158:77–79. Hamrick-Turner J, Abbitt PL, Ros PR. Intrahepatic cholangiocarcinoma: MR appearance. AJR 1992; 158:77–79.
19.
Zurück zum Zitat Schoefl R, Haefner M, Wrba F, Pfeffel F, Stain C, Poetzi R, Gangl A. Forceps biopsy and brush cytology during endoscopic retrograde cholangiopancreatography for the diagnosis of biliary stenosis. Scand J Gastroenterol 1997; 32:363–368.PubMed Schoefl R, Haefner M, Wrba F, Pfeffel F, Stain C, Poetzi R, Gangl A. Forceps biopsy and brush cytology during endoscopic retrograde cholangiopancreatography for the diagnosis of biliary stenosis. Scand J Gastroenterol 1997; 32:363–368.PubMed
20.
Zurück zum Zitat Glasbrenner B, Ardan M, Boeck W, Preclik G, Moller P, Adler G. Prospective evaluation of brush cytology of biliary strictures during ERCP. Endoscopy 1999; 31:712–717.CrossRefPubMed Glasbrenner B, Ardan M, Boeck W, Preclik G, Moller P, Adler G. Prospective evaluation of brush cytology of biliary strictures during ERCP. Endoscopy 1999; 31:712–717.CrossRefPubMed
21.
Zurück zum Zitat Feydy A, Vilgrain V, Denys A, Sibert A, Belghiti J, Vullierme MP, Menu Y. Helical CT assessment in hilar cholangiocarcinoma: correlation with surgical and pathologic findings. AJR 1999; 172:73–77. Feydy A, Vilgrain V, Denys A, Sibert A, Belghiti J, Vullierme MP, Menu Y. Helical CT assessment in hilar cholangiocarcinoma: correlation with surgical and pathologic findings. AJR 1999; 172:73–77.
22.
Zurück zum Zitat NakajimaT, Kondo Y, Miyazaki M, Okui K. A histopathologic study of 102 cases of intrahepatic cholangiocarcinoma: histologic classification and modes of spreading. Hum Pathol 1988; 19:1228–1234.PubMed NakajimaT, Kondo Y, Miyazaki M, Okui K. A histopathologic study of 102 cases of intrahepatic cholangiocarcinoma: histologic classification and modes of spreading. Hum Pathol 1988; 19:1228–1234.PubMed
Metadaten
Titel
Usefulness of 18F-FDG PET in intrahepatic cholangiocarcinoma
verfasst von
Young-Jin Kim
Mijin Yun
Woo Jung Lee
Kyung Sik Kim
Jong Doo Lee
Publikationsdatum
01.11.2003
Verlag
Springer-Verlag
Erschienen in
European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 11/2003
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-003-1297-8

Weitere Artikel der Ausgabe 11/2003

European Journal of Nuclear Medicine and Molecular Imaging 11/2003 Zur Ausgabe